Contracts › 75F40125F19007
75F40125F19007: Order Against 75F40121D00009 Qiagen Idiq for Purchase of Molecular Biology Reagents.
Awarded to Qiagen, Llc by Food and Drug Administration (FDA).
$35Kobligated
$35Kpotential value
14 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40125F19007 |
|---|---|
| Vehicle | 75F40121D00009 |
| Awardee | Qiagen, Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 325413 In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Place of performance | MD |
| Period of performance | 04 September 2025 to 14 December 2026 |
| Potential end | 14 December 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325413 contracts · All expiring contracts · USASpending record